disease modifying therapies

Are there any challenges associated with histological evaluation of DMTs?

Yes, there are several challenges. One major challenge is the heterogeneity of tissue samples, which can make it difficult to obtain consistent results. Additionally, some histological changes may be subtle and require advanced imaging and analysis techniques to detect. Another challenge is the interpretation of histological data, which can be subjective and may require correlation with clinical outcomes and other biomarkers.

Frequently asked queries:

Partnered Content Networks

Relevant Topics